AustralianSuper Pty Ltd acquired a new position in HCA Holdings, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 306,700 shares of the company’s stock, valued at approximately $24,410,000. HCA accounts for approximately 1.1% of AustralianSuper Pty Ltd’s portfolio, making the stock its 27th biggest position. AustralianSuper Pty Ltd owned 0.09% of HCA as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Parametric Portfolio Associates LLC lifted its position in shares of HCA by 4.2% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 1,346,771 shares of the company’s stock worth $107,190,000 after buying an additional 54,653 shares during the period. IFM Investors Pty Ltd bought a new position in shares of HCA during the 3rd quarter worth approximately $646,000. Yellowstone Partners LLC bought a new position in shares of HCA during the 3rd quarter worth approximately $5,802,000. Neuberger Berman Group LLC lifted its position in shares of HCA by 10.7% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,820,685 shares of the company’s stock worth $144,908,000 after buying an additional 176,494 shares during the period. Finally, California Public Employees Retirement System lifted its position in shares of HCA by 2.6% during the 3rd quarter. California Public Employees Retirement System now owns 886,829 shares of the company’s stock worth $70,583,000 after buying an additional 22,829 shares during the period. Institutional investors own 75.35% of the company’s stock.

HCA has been the subject of several analyst reports. Morgan Stanley cut their target price on HCA from $88.00 to $85.00 and set an “equal weight” rating for the company in a research report on Thursday, August 17th. Robert W. Baird cut their target price on HCA from $95.00 to $93.00 and set an “outperform” rating for the company in a research report on Tuesday, August 22nd. Cantor Fitzgerald restated a “buy” rating and set a $95.00 target price on shares of HCA in a research report on Wednesday, September 6th. ValuEngine downgraded HCA from a “buy” rating to a “hold” rating in a research report on Thursday, September 7th. Finally, KeyCorp reaffirmed a “buy” rating and set a $95.00 price target on shares of HCA in a report on Thursday, September 7th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and nineteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $90.20.

In other news, SVP Victor L. Campbell sold 8,000 shares of HCA stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total value of $624,000.00. Following the completion of the sale, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at approximately $9,927,450. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael S. Cuffe sold 2,150 shares of HCA stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the sale, the insider now directly owns 12,476 shares of the company’s stock, valued at $973,128. The disclosure for this sale can be found here. Insiders sold a total of 20,300 shares of company stock valued at $1,565,960 over the last three months. Insiders own 2.90% of the company’s stock.

HCA Holdings, Inc. (HCA) traded down $1.44 during mid-day trading on Friday, reaching $86.15. The company had a trading volume of 1,729,400 shares, compared to its average volume of 2,296,569. HCA Holdings, Inc. has a 12-month low of $71.18 and a 12-month high of $91.03. The firm has a market cap of $31,011.46, a PE ratio of 13.29, a price-to-earnings-growth ratio of 1.29 and a beta of 0.56. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41.

HCA (NYSE:HCA) last released its earnings results on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.21. The company had revenue of $10.70 billion during the quarter, compared to analysts’ expectations of $10.70 billion. HCA had a negative return on equity of 47.16% and a net margin of 6.13%. The business’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the firm earned $1.45 EPS. equities research analysts forecast that HCA Holdings, Inc. will post 6.56 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “AustralianSuper Pty Ltd Invests $24.41 Million in HCA Holdings, Inc. (HCA)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/12/15/australiansuper-pty-ltd-invests-24-41-million-in-hca-holdings-inc-hca.html.

HCA Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).

Institutional Ownership by Quarter for HCA (NYSE:HCA)

Receive News & Stock Ratings for HCA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA and related stocks with our FREE daily email newsletter.